Neural Cell Adhesion Molecule-180 Expression As a Prognostic Criterion in Colorectal Carcinoma: Feasible or Not?
Overview
Authors
Affiliations
Aim: To evaluate the frequency of neural cell adhesion molecule (NCAM)-180 expression in fresh tumor tissue samples and to discuss the prognostic value of NCAM-180 in routine clinical practice.
Methods: Twenty-six patients (16 men, 10 women) with colorectal cancer were included in the study. Fresh tumor tissue samples and macroscopically healthy proximal margins of each specimen were subjected to flow-cytometric analysis for NCAM-180 expression.
Results: Flow-cytometric analysis determined NCAM-180 expression in whole tissue samples of macroscopically healthy colorectal tissues. However, NCAM-180 expression was positive in only one case (3.84%) with well-differentiated Stage II disease who experienced no active disease at 30 mon follow-up.
Conclusion: As a consequence of the limited number of cases in our series, it might not be possible to make a generalisation, nevertheless the routine use of NCAM-180 expression as a prognostic marker for colorectal carcinoma seems to be unfeasible and not cost-effective in clinical practice due to its very low incidence.
Sowparani S, Mahalakshmi P, Sweety J, Francis A, Dhanalekshmi U, Selvasudha N Mol Neurobiol. 2022; 59(9):5902-5924.
PMID: 35831555 DOI: 10.1007/s12035-022-02954-9.
Lorenc Z, Opilka M, Kruszniewska-Rajs C, Rajs A, Waniczek D, Starzewska M Med Sci Monit. 2015; 21:2031-40.
PMID: 26167814 PMC: 4514365. DOI: 10.12659/MSM.893610.